The offering is one of four biotech IPOs that could price by Friday, and comes during the busiest week for such activity ...

Hemas Holdings PLC has reported cumulative earnings of Rs. 5.9 billion, up 7.5% year-on-year (YoY), for the nine months to ...

Mainland China's issuers will still dominate city's IPO market, executive says, but US and Southeast Asian companies are also ...

Major stock indexes finished sharply lower Tuesday, dragged by technology shares, although the Dow Jones Industrial Average hit a new all-time high before reversing course. Meanwhile, gold and silver ...

Novo Nordisk says the expiration of its patents for some semaglutide GLP-1 drug treatments in markets like Canada will result ...

Lilly's successes have boosted its ‍market value to more than $1 trillion, the first pharmaceutical ​company to reach that ...

Cencora is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With roughly $300 billion in annual US healthcare distribution sales, Cencora supplies ...

These five Goldman Sachs Conviction List stock picks have significant upside relative to their price targets and come with ...

Yet kratom’s advocates, while favoring more robust regulation of their product, say the legislation disproportionately ...

Gold and silver prices were also stronger following their sudden washouts over the last week. Gold rose 1.7% and rose to ...

Eli Lilly beat profit estimates and issued strong guidance as demand for its weight-loss drugs surged, even as pricing ...

Go behind the scenes with Jim Cramer and Jeff Marks of the CNBC Investing Club as they talk candidly about the market's biggest headlines, analyst calls and holdings in the Charitable Trust—and see up ...